Work

A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary Adenocarcinoma

Year: 2016

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2016.05.038

Authors: Tony Shu Kam Mok, Sarayut Lucien Geater, Wu-Chou Su, Eng-Huat Tan, James Chi-Hsin Yang, Gee-Chen Chang, May Han, Philip Komarnitsky, Francis Payumo, Jennifer E. Garrus, Sandra Close, Keunchil Park

Institutions: Chinese University of Hong Kong, Prince of Songkla University, National Cheng Kung University Hospital, National Cancer Centre Singapore, National Taiwan University Hospital, Taichung Veterans General Hospital, AVEO Oncology (United States), Samsung Medical Center, Sungkyunkwan University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2501877819

FWCI: 6.857

Cites: 30

Cited by: 57

Related to: 10